PFIZ34.SA Pfizer Inc

Healthcare Pharmaceuticals Sao Paulo Exchange
41.81 BRL
Close of Nov 5, 2026
30.08 42.62
Market cap
BRL 953B
P/E
45.9x
P/B
2.03x
ROE
5.7%
Dividend yield
3.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is PFIZ34.SA undervalued?

Graham number
Price41.81
Graham value20.54
Premium103.6%

PFIZ34.SA trades 103.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pfizer Inc fundamental analysis

No fundamental analysis for Pfizer Inc yet.

Pfizer Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, …

Full company profile